Patents by Inventor Daniel Weinfurtner

Daniel Weinfurtner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220213190
    Abstract: The present disclosure describes a pharmaceutical formulation of an anti-CD19 antibody.
    Type: Application
    Filed: March 22, 2022
    Publication date: July 7, 2022
    Inventors: Patrick GARIDEL, Andreas LANGER, Martin HESSLING, Daniel WEINFURTNER, Bodo BROCKS
  • Patent number: 11352423
    Abstract: The present disclosure describes a pharmaceutical formulation of an anti-CD19 antibody.
    Type: Grant
    Filed: June 27, 2017
    Date of Patent: June 7, 2022
    Assignee: MORPHOSYS AG
    Inventors: Patrick Garidel, Andreas Langer, Martin Hessling, Daniel Weinfurtner, Bodo Brocks
  • Publication number: 20210253692
    Abstract: The present disclosure describes high concentration liquid formulations of a pharmaceutically active antigen binding protein, for example a monoclonal antibody. Such formulations comprise, in addition to the antigen binding protein, at least 80 mM of a buffering agent and at least 80 mM of a stabilizer. In addition, the present disclosure is related to pharmaceutical formulations of an anti-IL-17C antibody and provides methods of making and methods of using such formulations.
    Type: Application
    Filed: July 2, 2019
    Publication date: August 19, 2021
    Inventors: Martin DOMNOWSKI, Roy EYLENSTEIN, Jan JAEHRLING, Daniel WEINFURTNER
  • Publication number: 20190322742
    Abstract: The present disclosure describes a pharmaceutical formulation of an anti-CD19 antibody.
    Type: Application
    Filed: June 27, 2017
    Publication date: October 24, 2019
    Inventors: Patrick Garidel, Andreas Langer, Martin Hessling, Daniel Weinfurtner, Bodo Brocks